Evidence map›Paper›PMID 33493140›Full record

ArticleAging2021

Cross-platform genomic identification and clinical validation of breast cancer diagnostic biomarkers.

Dongdong Liu, Beibei Li, Xiaoshun Shi, Jiexia Zhang, Allen Menglin Chen, Jiarui Xu, Wan Wang, Kailing Huang, Jinwei Gao, Zhouxia Zheng and 5 more

Open access · greenAbstract readValidation Study
In one paragraph

Article in Aging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Frontiers in oncology · 2025
    Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Dongdong LiuDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Beibei LiDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Xiaoshun ShiDepartment of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, P.R. China.
Jiexia ZhangDepartment of Respiratory, The First Affiliated Hospital of Guangzhou Medical University, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, Guangzhou 510120, P.R. China.
Allen Menglin ChenGuangzhou Mendel Genomics and Medical Technology Co., Ltd., Guangzhou 510530, P.R. China.
Jiarui XuDepartment of Laboratory Science, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen 518000, P.R. China.
Wan WangDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Kailing HuangGuangzhou Mendel Genomics and Medical Technology Co., Ltd., Guangzhou 510530, P.R. China.
Jinwei GaoGuangzhou Mendel Genomics and Medical Technology Co., Ltd., Guangzhou 510530, P.R. China.
Zhouxia ZhengGuangzhou Mendel Genomics and Medical Technology Co., Ltd., Guangzhou 510530, P.R. China.
Dan LiuDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Huimin WangDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Wen ShiDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Lin ChenDepartment of Laboratory Science, The Second Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510120, P.R. China.
Jianhua XuDepartment of Laboratory Science, Shunde Hospital of Guangzhou University of Chinese Medicine, Foshan 528300, P.R. China.
Guangzhou University of Chinese Medicine · CNShenzhen Pingle Orthopedic Hospital · CNSouthern Medical University · CNState Key Laboratory of Respiratory Disease · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCirculating non-coding RNA is an ideal source to discover novel biomarkers for non-invasive screening. However, studies for the discovery of universal miRNAs in serum and exosomes for breast cancer early diagnosis are limited.

methodsBased on bioinformatic analysis,

resultsThe expression of serum and exosomal hsa-miR-423-5p is abnormally increased in breast cancer. Suppression of hsa-miR-423-5p inhibited cell proliferation and invasion in both T47D and MDA-MB-231 breast cancer cell lines, and tumor growth

conclusionsA translational bioinformatics analysis procedure and validation by

Indexed as

Breast NeoplasmsCell Line, TumorCell MovementCell ProliferationFemaleHumansMicroRNAsMiddle AgedNeoplastic Stem CellsReproducibility of ResultsMicroRNAsMIRN423 microRNA, humanbiomarkersbreast cancerexosomehsa-miR-423-5pnon-coding RNA

Identifiers

PMID33493140
PMCPMC7906147
OpenAlexW3126045092

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.